Checchi Capital Advisers’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,124
Closed -$252K – 644
2026
Q1
$252K Buy
+1,124
New +$280K 0.01% 515
2025
Q4
– Sell
-794
Closed -$217K – 568
2025
Q3
$217K Sell
794
-128
-14% -$35K 0.01% 520
2025
Q2
$238K Buy
922
+7
+0.8% +$1.67K 0.01% 515
2025
Q1
$205K Buy
915
+8
+0.9% +$1.87K 0.01% 550
2024
Q4
$207K Sell
907
-10
-1% -$2.41K 0.01% 543
2024
Q3
$224K Buy
+917
New +$205K 0.01% 528
2023
Q3
– Sell
-1,664
Closed -$364K – 575
2023
Q2
$364K Buy
1,664
+18
+1% +$4.01K 0.03% 362
2023
Q1
$360K Buy
1,646
+16
+1% +$3.47K 0.03% 360
2022
Q4
$339K Sell
1,630
-203
-11% -$44.6K 0.04% 359
2022
Q3
$400K Buy
1,833
+32
+2% +$7.28K 0.04% 315
2022
Q2
$433K Buy
1,801
+582
+48% +$124K 0.04% 322
2022
Q1
$296K Buy
1,219
+80
+7% +$19.4K 0.03% 412
2021
Q4
$297K Buy
1,139
+48
+4% +$12.5K 0.03% 389
2021
Q3
$288K Buy
1,091
+30
+3% +$8.2K 0.03% 376
2021
Q2
$262K Sell
1,061
-144
-12% -$30.3K 0.03% 428
2021
Q1
$234K Sell
1,205
-222
-16% -$44.5K 0.02% 446
2020
Q4
$303K Buy
1,427
+41
+3% +$8.18K 0.03% 334
2020
Q3
$238K Sell
1,386
-164
-11% -$30.3K 0.03% 363
2020
Q2
$298K Buy
1,550
+85
+6% +$13.9K 0.04% 304
2020
Q1
$216K Buy
1,465
+92
+7% +$14.7K 0.02% 322
2019
Q4
$213K Buy
+1,373
New +$198K 0.03% 401
2016
Q3
– Sell
-828
Closed -$52K – 1025
2016
Q2
$52K Buy
828
+182
+28% +$10.7K 0.01% 823
2016
Q1
$37K Buy
+646
New +$36.6K 0.01% 922

Other funds holding RMD

Checchi Capital Advisers's RMD Position: Q2 2026 in Review

Checchi Capital Advisers sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,124 shares — an estimated $252K sold.

Checchi Capital Advisers first reported a position in RMD in Q1 2016 and held it in 23 quarters. The position peaked at $433K in Q2 2022. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Checchi Capital Advisers reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Checchi Capital Advisers sold 1,124 ResMed shares in Q2 2026, an estimated $252K.
  • Checchi Capital Advisers first reported a position in ResMed in Q1 2016 and held it in 23 quarters.
  • Checchi Capital Advisers's ResMed position peaked at $433K in Q2 2022.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.